Cited by 241Barrier Structure and Function StudiesDrug Transport and Resistance MechanismsNeuroinflammation and Neurodegeneration Mechanisms

Cytokine Signaling Modulates Blood-Brain Barrier Function

Open access
Pan, Weihong, P. Stone, Kirsten, Hsuchou, Hung, K. Manda, Vamshi, Zhang, Yan, J. Kastin, Abba·2011·Current Pharmaceutical Design

Abstract

The blood-brain barrier (BBB) provides a vast interface for cytokines to affect CNS function. The BBB is a target for therapeutic intervention. It is essential, therefore, to understand how cytokines interact with each other at the level of the BBB and how secondary signals modulate CNS functions beyond the BBB. The interactions between cytokines and lipids, however, have not been fully addressed at the level of the BBB. Here, we summarize current understanding of the localization of cytokine receptors and transporters in specific membrane microdomains, particularly lipid rafts, on the luminal (apical) surface of the microvascular endothelial cells composing the BBB. We then illustrate the clinical context of cytokine effects on the BBB by neuroendocrine regulation and amplification of inflammatory signals. Two unusual aspects discussed are signaling crosstalk by different classes of cytokines and genetic regulation of drug efflux transporters. We also introduce a novel area of focus on how cytokines may act through nuclear hormone receptors to modulate efflux transporters and other targets. A specific example discussed is the ATP-binding cassette transporter-1 (ABCA-1) that regulates lipid metabolism. Overall, cytokine signaling at the level of the BBB is a crucial feature of the dynamic regulation that can rapidly change BBB function and affect brain health and disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/138161211798220918

Cites

219 of 219 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 6

  1. [21]Pan W Xiang S Tu H Kastin AJ Dermietzel R Spray DC Nedergaard M In Blood-Brain Barrier Interfaces: From Ontogeny to Artificial Barriers 2006 247 64 Wiley-VCH Weinheim, Germany
  2. [76]Yu Y Kastin AJ Pan W Reciprocal interactions of insulin and IGF-1 in receptor-mediated transport across the BBB. Endocrinol 2006 147 2611 5 16497794
  3. [90]Tu H Kastin AJ Pan W CRH-R1 and CRH-R2 are both trafficking and signaling receptors for urocortin. Mol Endocrinol 2007 21 700 11 17170072
  4. [135]Tu H Kastin AJ Pan W CRH-R1 and CRH-R2 are both trafficking and signaling receptors for urocortin. Mol Endocrinol 2007 21 700 11 17170072
  5. [171]Tu H Kastin AJ Bjorbaek C Pan W Urocortin trafficking in cerebral microvessel endothelial cells. J Mol Neurosci 2007 31 171 82 17478891
  6. [189]Barger PM Browning AC Garner AN Kelly DP p38 mitogen-activated protein kinase activates peroxisome proliferator-activated receptor alpha: a potential role in the cardiac metabolic stress response. J Biol Chem 2001 276 48 44495 501 11577087

Cited by

Sorted by citations

Authors
Pan, W., P. Stone, K., Hsuchou, H., K. Manda, V., Zhang, Y., & J. Kastin, A.
Affiliations
Pennington Biomedical Research Center (US)
Venue
Current Pharmaceutical Design
Published
2011-11-01
Volume
17
Issue
33
Pages
3729-3740
ISSN
1381-6128 (ISSN-L)
OpenAlex
W2042991023
Cited by
241
References
210
Citations by year
2026: 15 · 2025: 16 · 2024: 19 · 2023: 23 · 2022: 24 · 2021: 25 · 2020: 29 · 2019: 20 · 2018: 22 · 2017: 12 · 2016: 8 · 2015: 16 · 2014: 6 · 2013: 4 · 2012: 2
FWCI
0.34
Type
journal article
Language
en
Open access
Locations
  • Current Pharmaceutical Design (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (DK54880)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK-54880, R01DK054880, R56DK054880)
  • National Institute of Neurological Disorders and Stroke (NS62291, R01NS062291)
Topics
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
blood-brain barrier, cytokine signaling, lipid rafts, cytokine receptors, efflux pumps, ABCA1, nuclear receptors, neuroinflammation, neuroendocrine regulation, signaling crosstalk, microvascular endothelial cells, lipid metabolism
MeSH terms
Animals, Blood-Brain Barrier, Carrier Proteins, Pharmaceutical Preparations, Humans, Inflammation, Ligands, Neuropeptides, Signal Transduction, Cytokines, Receptors, Cytoplasmic and Nuclear

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review